Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition.

World journal of gastroenterology - 14 Nov 2008

Iacobellis Angelo, Ippolito Antonio, Andriulli Angelo

Abstract excerpt

The main goals of treating cirrhotic patients with antiviral therapy are to attain sustained viral clearance (SVR), halt disease progression, and prevent re-infection of the liver graft. However, while the medical need is great, the use of interferon and ribavirin might expose these patients to severe treated-related side effects as a large proportion of them have pre-existing hematological cytopenias. We have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Graft Survival
Share to Hypertension, Portal
Share to Interferon alpha-2

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Liver Cirrhosis

Share to Liver Transplantation

Share to Polyethylene Glycols

Share to Ribavirin

Share to Secondary Prevention

Source

Open in PubMed Open full text

Identifiers

PMID: 19030197
DOI: 10.3748/wjg.14.6467
PMCID: PMC2773331

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition.PMID 19030197Read ↗

Antiviral Therapy in Patients with Hepatitis C Virus-Induced Cirrhosis.Semantic proximity Read ↗

Treatment of hepatitis C in patients with cirrhosis: remaining challenges for direct-acting antiviral therapy.Semantic proximity Read ↗

Management of HCV in cirrhosis-a rapidly evolving landscape.Semantic proximity Read ↗

Ribavirin in the treatment of chronic hepatitis C.Semantic proximity Read ↗

Regimens for Cirrhotic Patients.Semantic proximity Read ↗

Therapy of hepatitis C: from empiricism to eradication.Semantic proximity Read ↗

Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection.Semantic proximity Read ↗

Ribavirin in the treatment of hepatitis C.Semantic proximity Read ↗

Virus-related liver cirrhosis: molecular basis and therapeutic options.Semantic proximity Read ↗

Pegylated interferon alpha-2b plus ribavirin for naive patients with HCV-related cirrhosis.Semantic proximity Read ↗

Pegylated interferon alfa 2b and oral ribavirin in patients with HCV-related cirrhosis.Semantic proximity Read ↗

Role of ribavirin in interferon-free therapy for the treatment of hepatitisC virus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.